LumiraDx Limited

:LMDX   3:48:27 PM EDT
-0.24 (-2.66%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)397.67M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$81.1 Million
Adjusted EPS-$0.38
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

LumiraDx Limited Stock, :LMDX

3 More London Riverside, London, Argyll and Bute SE1 2AQ
United States of America
Number of Employees: 2


LumiraDX Ltd. engages in the provision of next-generation POC diagnostic company, which focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. The firm developed and launched the platform, which is an integrated system comprised of a small, versatile POC instrument, or Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, David Scott, and Jerry McAleer in 2014 and is headquartered in London, the United Kingdom.